InvestorsHub Logo
Followers 76
Posts 3281
Boards Moderated 0
Alias Born 03/16/2014

Re: None

Saturday, 12/20/2014 2:28:09 PM

Saturday, December 20, 2014 2:28:09 PM

Post# of 687210
The AGM summary that was kindly posted by another member said :

"5.When asked about a potential halt for efficacy at interim: They prefer to finish out the trial being that its so close to completion and that ensures the regulators will be on board. Otherwise FDA might not agree and since it would have to be unblinded they would have to start over if the FDA did not accept the halt."

Q. If the DMC suggest a halt at the 149th event next Spring BUT the Company decide to continue with the trial are we told that the halt was suggested by the DMC regardless of the companies decision ?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News